** Shares of Apollo Hospitals Enterprise APLH.NS climb ~3%
to 6,976.6 rupees
** Kotak Institutional Equities upgrades stock to "buy" from
"add", hikes fair value (FV) by 2% to 8,270 rupees ($95.59)
** New FV at ~22% premium on last close
** Brokerage says APLH's overall bed expansion over FY25-27
is lower than peers, which poses lower earnings risk amid
expansion spree in the sector
** Expects hospital segment to report sales and core profit
CAGR of 16% and 17%, respectively, over FY25-27, aided by higher
occupancies, steady scale-up plans
** Offline pharmacy growth to stay healthy as margins
continue to improve - Kotak
** Stock among top gainers on Nifty 50 index .NSEI , which
is down 0.8%
** Analysts' avg rating on stock is "buy", median PT is
8,179 rupees - LSEG
** APLH gained ~28% in 2024 vs ~9% rise in NSEI
($1 = 86.5190 Indian rupees)
(Reporting by Manvi Pant in Bengaluru)
((Manvi.Pant@thomsonreuters.com; +918447554364;))